French Hepatitis C (HCV) Patients Treated with Anti-viral Combinations Containing Pegylated Interferon (IFN), Ribavirin (RBV), Sofosbuvir (SOF), Ledipasvir (LDV), Velpatasvir (VEL) and/or Voxilaprevir (VOX): The Impact of Treatment on Patient-Reported Outcomes (PROs)

Cacoub Patrice P.; Bourliere Marc; Asselah Tarik; de Ledinghen Victor; Mathurin Philippe; Hezode Christophe; Henry Linda; Stepanova Maria; Younossi Zobair M.

首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >French Hepatitis C (HCV) Patients Treated with Anti-viral Combinations Containing Pegylated Interferon (IFN), Ribavirin (RBV), Sofosbuvir (SOF), Ledipasvir (LDV), Velpatasvir (VEL) and/or Voxilaprevir (VOX): The Impact of Treatment on Patient-Reported Outcomes (PROs)

【24h】

French Hepatitis C (HCV) Patients Treated with Anti-viral Combinations Containing Pegylated Interferon (IFN), Ribavirin (RBV), Sofosbuvir (SOF), Ledipasvir (LDV), Velpatasvir (VEL) and/or Voxilaprevir (VOX): The Impact of Treatment on Patient-Reported Outcomes (PROs)

机译：法国丙型肝炎（HCV）含有聚乙二醇干扰素（IFN），利巴韦林（RBV），Sofosbuvir（SOF），LEDIPASVIR（LDV），VELPATASVIR（VEL）和/或VoxILAPREVIR（VOX）的抗病毒组合患者：影响对患者报告的结果（专业）的治疗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Hepatology: Official Journal of the American Association for the Study of Liver Diseases》 |2017年第1期|共1页
作者
Cacoub Patrice P.; Bourliere Marc; Asselah Tarik; de Ledinghen Victor; Mathurin Philippe; Hezode Christophe; Henry Linda; Stepanova Maria; Younossi Zobair M.;
展开▼
作者单位

La Pitie Salpetriere Hosp APHP Internal Med &

Clinc Immunol Paris France;

Hosp St Joseph Marseille France;

Univ Paris Diderot Hepatol Dept Clichy France;

Hop Haut Leveque Hepatol Unit Pessac France;

CHRU Lille Sce MAD Lille France;

Hosp Henri Mondor Hepatol Creteil France;

Ctr Outcomes Res Liver Dis Washington DC USA;

Inova Fairfax Hosp Dept Med Ctr Liver Dis Falls Church VA USA;

Inova Fairfax Hosp Dept Med Ctr Liver Dis Falls Church VA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. French Hepatitis C (HCV) Patients Treated with Anti-viral Combinations Containing Pegylated Interferon (IFN), Ribavirin (RBV), Sofosbuvir (SOF), Ledipasvir (LDV), Velpatasvir (VEL) and/or Voxilaprevir (VOX): The Impact of Treatment on Patient-Reported Outcomes (PROs) [J] . Cacoub Patrice P., Bourliere Marc, Asselah Tarik, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：法国丙型肝炎（HCV）含有聚乙二醇干扰素（IFN），利巴韦林（RBV），Sofosbuvir（SOF），LEDIPASVIR（LDV），VELPATASVIR（VEL）和/或VoxILAPREVIR（VOX）的抗病毒组合患者：影响对患者报告的结果（专业）的治疗
2. The levels of monoamine neurotransmitters and measures of mental and emotional health in HCV patients treated with ledipasvir (LDV) and sofosbuvir (SOF) with or without ribavirin (RBV) [J] . Golabi Pegah, Elsheikh Elzafir, Karrar Azza, Medicine. . 2016,第46期

机译：HCV患者单胺神经递质和精神和情绪健康措施的水平，用ledipasvir（LDV）和Sofosbuvir（SOF），或没有利巴韦林（RBV）
3. The levels of monoamine neurotransmitters and measures of mental and emotional health in HCV patients treated with ledipasvir (LDV) and sofosbuvir (SOF) with or without ribavirin (RBV) [J] . Golabi Pegah, Elsheikh Elzafir, Karrar Azza, Medicine. . 2016,第46期

机译：用ledipasvir（LDV）和Sofosbuvir（SOF）治疗的HCV患者单胺神经递质和心理和情绪健康措施的水平，或没有利韦韦林（RBV）
4. The levels of monoamine neurotransmitters and measures of mental and emotional health in HCV patients treated with ledipasvir (LDV) and sofosbuvir (SOF) with or without ribavirin (RBV) [O] . Pegah Golabi, Elzafir Elsheikh, Azza Karrar, -1

机译：利迪帕韦（LDV）和索非布韦（SOF）联合利巴韦林（RBV）和不联合利巴韦林（RBV）治疗的HCV患者的单胺神经递质水平和心理健康状况
5. The levels of monoamine neurotransmitters and measures of mental and emotional health in HCV patients treated with ledipasvir (LDV) and sofosbuvir (SOF) with or without ribavirin (RBV) [O] . Pegah Golabi, Elzafir Elsheikh, Azza Karrar, 2016

机译：用ledipasvir（LDV）和Sofosbuvir（SOF）治疗的HCV患者单胺神经递质和心理和情绪健康措施的水平，或没有利韦韦林（RBV）

French Hepatitis C (HCV) Patients Treated with Anti-viral Combinations Containing Pegylated Interferon (IFN), Ribavirin (RBV), Sofosbuvir (SOF), Ledipasvir (LDV), Velpatasvir (VEL) and/or Voxilaprevir (VOX): The Impact of Treatment on Patient-Reported Outcomes (PROs)

著录项

相似文献

相关主题

期刊订阅